Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200

NCT01585181 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholera

Interventions

BIOLOGICAL: PXVX0200
BIOLOGICAL: Placebo

Sponsor

Bavarian Nordic

Collaborators

[object Object]